4.7 Article

Cyclophilin Inhibition Protects Against Experimental Acute Kidney Injury and Renal Interstitial Fibrosis

期刊

出版社

MDPI
DOI: 10.3390/ijms22010271

关键词

cyclophilin; acute kidney injury; cell death; chronic kidney disease; inflammation; macrophage; neutrophil; renal fibrosis

资金

  1. National Health and Medical Research Council of Australia [1058175]
  2. Gilead Sciences
  3. Australian Postgraduate Award
  4. National Health and Medical Research Council of Australia [1058175] Funding Source: NHMRC

向作者/读者索取更多资源

The study demonstrated that the selective cyclophilin inhibitor GS-642362 effectively protected against acute kidney injury and renal fibrosis in mouse models. The treatment reduced cell death, inflammatory cell infiltration, and fibrosis, supporting further investigation of cyclophilin blockade in various kidney diseases.
Cyclophilins have important homeostatic roles, but following tissue injury, cyclophilin A (CypA) can promote leukocyte recruitment and inflammation, while CypD can facilitate mitochondrial-dependent cell death. This study investigated the therapeutic potential of a selective cyclophilin inhibitor (GS-642362), which does not block calcineurin function, in mouse models of tubular cell necrosis and renal fibrosis. Mice underwent bilateral renal ischemia/reperfusion injury (IRI) and were killed 24 h later: treatment with 10 or 30 mg/kg/BID GS-642362 (or vehicle) began 1 h before surgery. In the second model, mice underwent unilateral ureteric obstruction (UUO) surgery and were killed 7 days later; treatment with 10 or 30 mg/kg/BID GS-642362 (or vehicle) began 1 h before surgery. GS-642362 treatment gave a profound and dose-dependent protection from acute renal failure in the IRI model. This protection was associated with reduced tubular cell death, including a dramatic reduction in neutrophil infiltration. In the UUO model, GS-642362 treatment significantly reduced tubular cell death, macrophage infiltration, and renal fibrosis. This protective effect was independent of the upregulation of IL-2 and activation of the stress-activated protein kinases (p38 and JNK). In conclusion, GS-642362 was effective in suppressing both acute kidney injury and renal fibrosis. These findings support further investigation of cyclophilin blockade in other types of acute and chronic kidney disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据